bioMérieux: 9m revenues up over 10%.
(CercleFinance.com) - bioMérieux has reported revenues of 1,674 million euros over the first nine months of 2017, up 10.
8% as reported. At a constant consolidation scope and exchange rates, organic sales growth reached 10.7% y-o-y.
The in-vitro diagnosis specialist reported growth that accelerated to nearly 8% in microbiology, with all regions contributing, and particularly Asia-Pacific, China and the India reporting sales growth of close to 15%.
The good growth from microbiology ranges and a continuation in steady growth of molecular biology put us well on track to achieving our annual targets, said CEO Alexandre Mérieux.
Copyright (c) 2017 CercleFinance.com. All rights reserved.
8% as reported. At a constant consolidation scope and exchange rates, organic sales growth reached 10.7% y-o-y.
The in-vitro diagnosis specialist reported growth that accelerated to nearly 8% in microbiology, with all regions contributing, and particularly Asia-Pacific, China and the India reporting sales growth of close to 15%.
The good growth from microbiology ranges and a continuation in steady growth of molecular biology put us well on track to achieving our annual targets, said CEO Alexandre Mérieux.
Copyright (c) 2017 CercleFinance.com. All rights reserved.